Abstract
Purpose: The purpose is to study the incidence, characteristics, management, and visual outcome of endophthalmitis postintravitreal bevacizumab (Avastin®) injections. Methods: Retrospective cohort study conducted at Fauji Foundation Hospital that is a tertiary care center in Rawalpindi, Pakistan. The study duration was from January 1, 2015 to March 31, 2020. A total of 2321 eyes of 1407 patients were treated with Intravitreal bevacizumab (IVB) in a minor operation theater using standard aseptic measures. We studied the incidence, clinical characteristics, treatment, and visual outcomes of endophthalmitis post-IVB. Results: Seven eyes (0.30%) out of 2321 eyes developed post-IVB endophthalmitis during the study period. Three eyes (42.8%) were culture positive and four eyes (57.2%) were culture negative. Five eyes (71.4%) showed visual improvement and two eyes (28.6%) did not show visual improvement. Conclusion: Prompt intravitreal antibiotic along with vitreous tap in cases of postintravitreal endophthalmitis may prevent vision loss which provides a useful alternative to immediate pars plana vitrectomy that requires more expertise, equipment, and an operation theater.
Keywords
Publication details
- DOI
- 10.4103/ojo.ojo_103_21
- Journal
- Oman Journal of Ophthalmology, 15(1), 20-24
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Rizwan, A., Asghar, A., Sughra, U., & Yasmin, N. (2022). Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan. Oman Journal of Ophthalmology, 15(1), 20-24. https://doi.org/10.4103/ojo.ojo_103_21
MLA 9
Rizwan, Amna, et al. "Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan." Oman Journal of Ophthalmology, vol. 15, no. 1, 2022, pp. 20-24. https://doi.org/10.4103/ojo.ojo_103_21.
Chicago (author–date)
Rizwan, Amna, Asfandyar Asghar, Ume Sughra, and Naila Yasmin. 2022. "Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan." Oman Journal of Ophthalmology 15 (1): 20-24. https://doi.org/10.4103/ojo.ojo_103_21.
Harvard
Rizwan, A., Asghar, A., Sughra, U. and Yasmin, N. (2022) 'Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan', Oman Journal of Ophthalmology, 15(1), pp. 20-24. doi:10.4103/ojo.ojo_103_21.
Vancouver
Rizwan A, Asghar A, Sughra U, Yasmin N. Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan. Oman Journal of Ophthalmology. 2022;15(1):20-24. doi:10.4103/ojo.ojo_103_21
IEEE
A. Rizwan, A. Asghar, U. Sughra, and N. Yasmin, "Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan," Oman Journal of Ophthalmology, vol. 15, no. 1, pp. 20-24, 2022, doi: 10.4103/ojo.ojo_103_21.